Exodus Point Capital Management, LP Recursion Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 61,689 shares of RXRX stock, worth $451,563. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,689Holding current value
$451,563% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding RXRX
# of Institutions
260Shares Held
192MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$180 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$176 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$117 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$90.2 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V710.4MShares$76.2 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.32B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...